Released Friday, the government's report showed the unemployment rate falling to 6.7%. But it estimated the U.S. labor force shrank by 347,000 last month while only 74,000 new jobs were added. Just 62.8% of adults were working or sought jobs, tied for the lowest share since 1978.
For the year, the labor force shrank by nearly 550,000 workers to about 154.9 million ��marking only the third year since 1948 when the U.S. workforce declined on an annual basis.
To skeptical economists like Keith Hall of George Mason University, that means all of 2013's drop in the unemployment rate was because fewer people were looking. Only 2.2 million jobs were added last year.
Best Healthcare Technology Companies To Buy For 2015: CardioNet Inc.(BEAT)
CardioNet, Inc. provides real-time ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health to cardiologists and electro physiologists in the United States. The company focuses on the diagnosis and monitoring of cardiac arrhythmias through its Mobile Cardiac Outpatient Telemetry (MCOT) system, and event and Holter monitors. Its MCOT system is a real-time arrhythmia monitoring solution that incorporates a patient-worn sensor attached to leads, which captures ECG data and communicates wirelessly with a compact monitor that analyzes incoming information by applying proprietary algorithms and automatically transmits the ECG data to the CardioNet Monitoring Center, where cardiac monitoring specialists analyze the sent data and report results in the manner prescribed by the physician. The company also provides event monitoring services by using event monitors to record and store up to 540 seconds of ECG signal; Holter monito ring services by using Holter monitors to record a continuous ECG signal for one to two days; and pacemaker monitoring services for the periodic monitoring and evaluation of pacemakers implanted on patients. In addition, it engages in the development, manufacture, and marketing of medical devices and related software to medical companies, clinics, and hospitals. CardioNet, Inc. was incorporated in 1994 and is headquartered in Conshohocken, Pennsylvania.
Advisors' Opinion:- [By Bryan Murphy]
Look out Intuitive Surgical, Inc. (NASDAQ:ISRG), and step aside BioTelemetry Inc. (NASDAQ:BEAT). There's a new cardiac name in town, and its name is Stereotaxis Inc. (NASDAQ:STXS). This small company's stock is soaring today on the heels of encouraging news, though the prompt for the stock's strength has been brewing for quite some time. This nudge for STXS, however, may well mean it has a lot more potential than ISRG or BEAT do for the foreseeable future.
- [By Roberto Pedone]
Coming it at just above $10 is BioTelemetry (BEAT), which provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. This stock has been exploding to the upside in 2013, with shares up a whopping 342%.
If you take a look at the chart for BioTelemetry, you'll notice that this stock has been uptrending strong for the last four months, with shares moving higher from its low of $3.09 to its recent high of $10.90 a share. During that uptrend, shares of BEAT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of BEAT within range of triggering a major breakout trade.
Traders should now look for long-biased trades in BEAT if it manages to break out above some near-term overhead resistance levels at $10.63 to its 52-week high at $10.90 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 833,131 shares. If that breakout triggers soon, then BEAT will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $13 to $15 a share.
Traders can look to buy BEAT off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $9.52 to $8.94 a share, or just below its 50-day at $8.51 a share. One can also buy BEAT off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Hot Dow Dividend Companies To Buy For 2014: Humboldt Capital Corp (HMB)
Humboldt Capital Corporation (Humboldt) is an investment company with its holdings concentrated in the resource sector. The Company�� principal business is to purchase securities for investment income and capital appreciation over the long term. The Company provides early-stage risk capital, business experience and guidance to junior oil and gas enterprises. Humboldt is engaged in making investments in a range of very small to large companies, which are in turn engaged in the exploration, development, production and acquisition of crude oil and natural gas or minerals, or companies, which provides services to such companies. Humboldt also makes investments in other businesses that have potential for growth. Humboldt has investments in western Canadian energy companies, international oil and gas companies and in the mining sector, with particular emphasis on companies exploring or producing commodities. Advisors' Opinion:- [By Inyoung Hwang]
EasyJet Plc and International Consolidated Airlines Group SA climbed as oil prices fell after the U.S. and Russia agreed on a plan to destroy Syrian chemical weapons. Hennes & Mauritz AB (HMB) advanced to a three-year high after sales topped estimates. Remy Cointreau SA (RCO) soared the most in almost four years as Chinese cognac shipments increased.
Hot Dow Dividend Companies To Buy For 2014: SemiLEDS Corporation(LEDS)
SemiLEDs Corporation engages in the development, manufacture, and sale of light emitting diode (LED) chips and LED components. Its products are used primarily for general lighting applications, including street lights and commercial, industrial, and residential lighting, as well as in backlighting, medical, automotive, and ultra violet (UV) applications. The company markets blue, green, and UV LED chips under the MvpLED brand name primarily to customers in China and Taiwan, as well as in Russia and North America. It sells LED chips to packagers and distributors, who in turn sell to packaging customers. SemiLEDs Corporation was founded in 2005 and is based in Miao-Li County, Taiwan.
Advisors' Opinion:- [By Stock Investor]
Next up I will look at SemiLEDs Corporation (LEDS). This company is based in China, typically a red flag from the start. In the last year LEDS posted almost $26m in revenue with a net cash balance of approximately $36m. The market cap here is a small $42m, much cheaper than RVLT. LEDS has an average quarterly cash burn of about $5m, leaving them ample funding for the next two years at current spend rates. So far the financials here suggest that LEDS is undervalued, especially when compared to RVLT. Usually, however where there is smoke there is fire. In 2012 LEDS lost a patent infringement suit against CREE Inc (CREE). The settlement prevents LEDS from selling it product in the US, a major red flag. This is also the likely reason for such a large drop in sales over the last year of almost 40%. Revenue for the second quarter of fiscal 2013 was $4.8 million, a 39% decrease compared to $7.9 million in the second quarter of fiscal 2012. It is disconcerting that a company in a sector that is supposedly experiencing record growth, is seeing its sales drop this much. A major red flag for investors. While the cash position is a positive, investors should note that this is a China based company. Accurate financials are not something Chinese companies are know for.
- [By Victor Selva]
On Nov. 21, Robert Karr bought Veeco Instruments Inc. (VECO), a company that designs, manufactures and markets equipment to make light emitting diodes (LEDs), solar panels, hard-disk drives and other devices.
- [By Paul Ausick]
Just a week earlier SemiLEDS Corp. (NASDAQ: LEDS) said that it had received a delisting notice from Nasdaq for failing to maintain a share price of at least $1 a share. The company also faced several class action lawsuits as earnings tanked after a dramatic run-up in April. Shares rose nearly 15% after Revolution�� October announcement.
Hot Dow Dividend Companies To Buy For 2014: Snam SpA (SRG)
Snam SpA is an Italy-based company engaged in the management of natural gas services. The Company is diversified into four operating segments. The Transportation segment covers transportation-related gas services, including capacity management and transportation of the gas at the entry points of the gas network to the redelivery points. It owns transportation infrastructures of gas pipelines. The Regasification segment is focused on extraction activities of natural gas, its liquefaction for transport by ship and subsequent regasification. The Storage segment covers deposits, gas treatment plants, compression plants and the operational dispatching system. The Distribution segment engages gas distribution through local transportation networks from delivery points at the metering and reduction stations to the gas distribution network redelivery points at the end customers. Additionally, Snam SpA as the parent company, focuses on planning, management, coordination and control of the group. Advisors' Opinion:- [By Tom Stoukas]
Snam SpA (SRG) dropped the most in almost a year as Eni SpA sold an 11.7 percent stake in the owner of Italy�� biggest natural-gas network. Wm Morrison Supermarkets Plc tumbled the most in more than 14 months. Experian Plc jumped to a record after the world�� largest credit-checking company raised its dividend and announced a share buyback.
- [By Victor Selva]
The Specialty Restaurant Group (SRG), which includes Bahama Breeze and The Capital Grille, has grown over the last couple of quarters. Eddie V's Restaurants and Yard House might be meaningful long-term drivers, as we think most of the growth in the next years will come from the acquisition of those restaurants.
Hot Dow Dividend Companies To Buy For 2014: HopFed Bancorp Inc.(HFBC)
HopFed Bancorp, Inc. operates as the holding company for Heritage Bank that provides various banking products and services primarily in western Kentucky, and middle and western Tennessee. The company offers a range of deposit products, including demand deposits, time deposits, money market accounts, passbook savings accounts, individual retirement accounts, and certificates of deposit. Its loan portfolio comprises one-to-four family residential loans, multifamily residential loans, construction loans, nonresidential loans, commercial real estate loans, and land and land development loans, as well as loans secured by deposits, other consumer loans, and commercial loans. The company, through its subsidiary, Fall and Fall Insurance Agency, sells life and casualty insurance products to individuals and businesses. HopFed Bancorp offers its products and services through its branch offices located in Hopkinsville, Murray, Cadiz, Elkton, Fulton, Calvert City, and Benton, Kentucky; and in Clarksville, Pleasant View, Ashland City, Kingston Springs, and Erin, Tennessee. The company was founded in 1879 and is headquartered in Hopkinsville, Kentucky.
Advisors' Opinion:- [By Louis Navellier]
HopFed Bancorp (HFBC), at $85 million in market cap, operates 18 branches in middle Tennessee and Western Kentucky and can be thought of as poster child for what is going on in the small banking sector. An activist investor took a stake in the bank and opposed an ill-advised acquisition. Instead, he suggested HopFed management get its own house in order. Management went along and canceled the deal, instituted a stock buyback plan and doubled the dividend. HFBC was upgraded to an “A” back in May and still is a “strong buy” right now.
Hot Dow Dividend Companies To Buy For 2014: Mellanox Technologies Ltd.(MLNX)
Mellanox Technologies, Ltd., a fabless semiconductor company, engages in the design, development, marketing, and sale of interconnect products primarily in North America, Israel, Europe, and Asia. It offers semiconductor interconnect products that facilitate data transmission between servers, communications infrastructure equipment, and storage systems in enterprise data centers, high-performance computing, and embedded systems. The company provides solutions based on InfiniBand, including host channel adapter, switch and gateway ICs, adapter cards, switch and gateway systems, cables, and software. Its products also support the Ethernet standard. The company provides adapters to server, storage, communications infrastructure, and embedded systems OEMs as ICs or standard card form factors with PCI-X or PCI express interfaces; support server operating systems, including Linux, Windows, AIX, HPUX, Solaris, and VxWorks; and InfiniBand switch ICs to server, storage, communicati ons infrastructure, and embedded systems OEMs to create switching equipment. The company offers its products under the Mellanox, BridgeX, ConnectX, InfiniBlast, InfiniBridge, InfiniHost, InfiniPCI, InfiniRISC, PhyX, InfiniScale, and Virtual Protocol Interconnect trademarks in the United States. It primarily serves enterprise data center, high-performance computing, and embedded end-user markets, as well as embedded systems OEMs. The company sells its products directly, as well as through a network of domestic and international sales representatives, and independent distributors. Mellanox Technologies, Ltd. was incorporated in 1999 and is headquartered in Yokneam, Israel.
Advisors' Opinion:- [By Jake L'Ecuyer]
Top losers in the sector included CommVault Systems (NASDAQ: CVLT), off 28 percent, and Mellanox Technologies (NASDAQ: MLNX), down 13 percent.
Top Headline
Ford Motor Co (NYSE: F) reported a drop in its first-quarter profit. Ford's quarterly profit slipped to $989 million, or $0.24 per share, versus a year-ago profit of $1.61 billion, or $0.40 per share. Its revenue rose to $35.9 billion versus $35.6 billion. However, analysts were projecting earnings of $0.31 per share on revenue of $34.54 billion. - [By Roberto Pedone]
Mellanox Technologies (MLNX), a fabless semiconductor company, designs, manufactures and sells interconnect products and solutions. This stock closed up 6.1% at $36.67 in Monday's trading session.
Monday's Volume: 751,000
Three-Month Average Volume: 479,653
Volume % Change: 65%From a technical perspective, MLNX ripped sharply higher here right above its 50-day moving average of $33.57 with above-average volume. This big spike to the upside on Monday is quickly pushing shares of MLNX within range of triggering a near-term breakout trade. That trade will hit if MLNX manages to take out its 200-day moving average of $37.06 to some more near-term overhead resistance at $38.03 with high volume.
Traders should now look for long-biased trades in MLNX as long as it's trending above Monday's intraday low of $34.60 or above some more near-term support at $33.33 and then once it sustains a move or close above those breakout levels with volume that's near or above 479,653 shares. If that breakout begins soon, then MLNX will set up to re-test or possibly take out its next major overhead resistance levels at $40.80 to $44.14.
Hot Dow Dividend Companies To Buy For 2014: Peregrine Pharmaceuticals Inc.(PPHM)
Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the research and development of monoclonal antibodies for the treatment of cancer and viral infections. Its products under development include bavituximab, a phosphatidylserine-targeting antibody, which is in Phase II trials for the treatment of front-line and second-line non-small cell lung cancer (NSCLC), and pancreatic cancer; and Cotara, a DNA/histone-targeting antibody that is in Phase II trial for the treatment of recurrent glioblastoma multiforme. The company is also developing bavituximab in combination with ribavirin, which is in Phase II clinical trial for the treatment of patients with genotype-1 hepatitis C virus infection. In addition, it has investigator-sponsored trial programs that evaluate bavituximab for the treatment of patients with liver cancer, second-line castration resistant prostate cancer, HER-2 negative metastatic breast cancer, and locally advanced or metasta tic NSCLC. Further, the company, through its wholly-owned subsidiary, Avid Bioservices, Inc., provides integrated current Good Manufacturing Practices (cGMP) commercial and clinical manufacturing services in the United States, including contract manufacturing of antibodies, recombinant proteins, and enzymes; cell culture development; process development; and testing of biologics for biopharmaceutical and biotechnology companies under cGMP. It has licensing agreements with the University of Texas Southwestern Medical Center; Merck KGaA; SuperGen, Inc.; and Affitech A/S. Peregrine Pharmaceuticals, Inc. intends to sell its products in the United States and internationally in collaboration with marketing partners or through a direct sales force. The company was founded in 1981 and is based in Tustin, California.
Advisors' Opinion:- [By Rick Munarriz]
I went out on a limb last week, and now it's time to see how that decision played out.
I predicted that Noodles & Co. (NASDAQ: NDLS ) would close lower on the week. After seeing the fresh IPO more than double and command a $1.3 billion market cap far sooner than its fundamentals should allow, I figured it would be in for reality check. A negative Barron's piece kicked off the week in the seemingly appropriate bearish tone, but the shares did start to claw their way back later in the week. It wasn't enough. The shares fell 3% on the week. I was right. I predicted that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average. (DJINDICES: ^DJI ) . This has been a tricky call lately, so how did it play out this time? Well, the market closed nicely higher this week. The Nasdaq moved 3.5% higher, and the Dow managed to close just 2.2% higher. I was right. My final call was for Peregrine Pharmaceuticals (NASDAQ: PPHM ) to beat Wall Street's income estimates in its latest quarter. The upstart biotech tackling cancer through monoclonal antibodies has been posting blowout quarterly results over the past year, and I was banking on seeing the trend continue. Analysts were looking for a loss of $0.06 a share during the quarter, and it came through with exactly that. It wasn't a beat, though, so I was wrong.Two out of three? I can do better than that.
- [By Rick Munarriz]
Peregrine Pharmaceuticals (NASDAQ: PPHM ) is an upstart biotech targeting the treatment and diagnosis of cancer through monoclonal antibodies. It has a potential winner in its lead candidate that will begin its telltale phase 3 clinical trial later this year.
- [By Tom Bemis]
Few major companies are reporting after Monday�� bell. Results are expected from Destiny Media Technologies (DSNY) �, Stanley Furniture Co. (STLY) � and Peregrine Pharmaceuticals. (PPHM) �.
No comments:
Post a Comment